PL2207567T3 - Preparat immunogenny - Google Patents
Preparat immunogennyInfo
- Publication number
- PL2207567T3 PL2207567T3 PL08832386T PL08832386T PL2207567T3 PL 2207567 T3 PL2207567 T3 PL 2207567T3 PL 08832386 T PL08832386 T PL 08832386T PL 08832386 T PL08832386 T PL 08832386T PL 2207567 T3 PL2207567 T3 PL 2207567T3
- Authority
- PL
- Poland
- Prior art keywords
- immunogenic formulation
- immunogenic
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2007002710A CL2007002710A1 (es) | 2007-09-20 | 2007-09-20 | Formulacion inmunogenica que confiere proteccion contra la infeccion o patologia causada por el virus respiratorio sincicial (vrs) que comprende una cepa recombinante atenuada de mycobacterium; y uso de la formulacion inmunogenica para preparar una vacuna para prevenir, tratar o atenuar infecciones del vrs. |
PCT/US2008/076682 WO2009039178A1 (en) | 2007-09-20 | 2008-09-17 | Immunogenic formulation |
EP08832386.0A EP2207567B1 (en) | 2007-09-20 | 2008-09-17 | Immunogenic formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2207567T3 true PL2207567T3 (pl) | 2015-06-30 |
Family
ID=51399051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08832386T PL2207567T3 (pl) | 2007-09-20 | 2008-09-17 | Preparat immunogenny |
Country Status (10)
Country | Link |
---|---|
US (1) | US8398993B2 (pl) |
EP (1) | EP2207567B1 (pl) |
CN (1) | CN101918029B (pl) |
AR (2) | AR067425A1 (pl) |
CL (1) | CL2007002710A1 (pl) |
DK (1) | DK2207567T3 (pl) |
ES (1) | ES2528197T3 (pl) |
PE (1) | PE20090653A1 (pl) |
PL (1) | PL2207567T3 (pl) |
WO (1) | WO2009039178A1 (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102021149B (zh) * | 2010-07-27 | 2013-04-24 | 张卫东 | 基因ns1缺陷型呼吸道合胞病毒及其治疗肺癌的应用 |
WO2013155205A1 (en) | 2012-04-10 | 2013-10-17 | The Trustees Of The University Of Pennsylvania | Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same |
WO2014005643A1 (en) * | 2012-07-05 | 2014-01-09 | Okairos Ag | Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides |
CL2013002829A1 (es) * | 2013-10-01 | 2014-04-04 | Univ Pontificia Catolica Chile | Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv. |
MX2016016533A (es) | 2014-06-13 | 2017-05-01 | Glaxosmithkline Biologicals Sa | Combinaciones inmunogenas. |
CN104593389A (zh) * | 2015-01-27 | 2015-05-06 | 吉林大学 | 一种重组合胞病毒蛋白及其应用 |
CL2019003847A1 (es) * | 2019-12-26 | 2021-08-06 | Univ Pontificia Catolica Chile | Nuevo uso de formulación inmunogénica bcg que expresa una proteína de virus respiratorio sincicial contra hmpv |
CL2020000857A1 (es) | 2020-03-31 | 2021-11-05 | Univ Pontificia Catolica Chile | Nuevo uso de formulación inmunogénica bcg que expresa una proteína del virus respiratorio sincicial humano contra bvrs en bovinos |
CN114748615A (zh) * | 2022-04-29 | 2022-07-15 | 成都安永鼎业生物技术有限公司 | 一种治疗用重组卡介苗的冻干制剂及其制备方法和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0590027A4 (en) * | 1991-06-13 | 1994-10-19 | Einstein Coll Med | MUTATIONS IN MYCOBACTERIES BY INSTALLATION. |
US6566121B1 (en) * | 1991-06-13 | 2003-05-20 | Albert Einstein College Of Medicine Of Yeshiva University | Insertional mutations in mycobacteria |
US20020081317A1 (en) * | 1999-02-02 | 2002-06-27 | Mahan Michael J. | Bacteria with altered DNA adenine methylase (DAM) activity and heterologous epitope |
EP1305043A2 (en) * | 2000-07-31 | 2003-05-02 | Aventis Pasteur Limited | Respiratory syncytial virus vaccine |
US7285281B2 (en) * | 2001-06-07 | 2007-10-23 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
US7070786B2 (en) * | 2003-06-06 | 2006-07-04 | Centocor, Inc. | RSV proteins, antibodies, compositions, methods and uses |
EP1830877A2 (en) * | 2004-12-01 | 2007-09-12 | Aeras Global TB Vaccine Foundation | Recombinant bcg strains with attenuated immunosuppresive properties |
-
2007
- 2007-09-20 CL CL2007002710A patent/CL2007002710A1/es unknown
-
2008
- 2008-09-17 WO PCT/US2008/076682 patent/WO2009039178A1/en active Search and Examination
- 2008-09-17 DK DK08832386.0T patent/DK2207567T3/en active
- 2008-09-17 ES ES08832386.0T patent/ES2528197T3/es active Active
- 2008-09-17 EP EP08832386.0A patent/EP2207567B1/en active Active
- 2008-09-17 US US12/679,091 patent/US8398993B2/en active Active - Reinstated
- 2008-09-17 CN CN200880114324.0A patent/CN101918029B/zh active Active
- 2008-09-17 PL PL08832386T patent/PL2207567T3/pl unknown
- 2008-09-18 AR ARP080104064A patent/AR067425A1/es not_active Application Discontinuation
- 2008-09-18 PE PE2008001628A patent/PE20090653A1/es active IP Right Grant
-
2019
- 2019-06-18 AR ARP190101676A patent/AR116662A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2207567B1 (en) | 2014-11-05 |
CN101918029B (zh) | 2015-05-20 |
CN101918029A (zh) | 2010-12-15 |
ES2528197T3 (es) | 2015-02-05 |
AR116662A2 (es) | 2021-06-02 |
PE20090653A1 (es) | 2009-06-20 |
CL2007002710A1 (es) | 2008-01-04 |
DK2207567T3 (en) | 2015-01-26 |
US8398993B2 (en) | 2013-03-19 |
EP2207567A4 (en) | 2013-05-01 |
EP2207567A1 (en) | 2010-07-21 |
WO2009039178A1 (en) | 2009-03-26 |
AR067425A1 (es) | 2009-10-14 |
US20110200634A1 (en) | 2011-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200808489B (en) | Nicotine-carrier vaccine formulation | |
GB0711656D0 (en) | Formulations | |
GB0716385D0 (en) | Formulations | |
GB0815435D0 (en) | Formulations | |
EP2344522A4 (en) | COMBINATION ADJUVANT FORMULATION | |
GB0720716D0 (en) | Novel formulation | |
GB0712884D0 (en) | Formulations | |
GB0823269D0 (en) | Formulations | |
ZA201004439B (en) | Formulation | |
GB0809979D0 (en) | Formulations | |
GB0711957D0 (en) | Formulations | |
ZA201102446B (en) | Oral formulation | |
GB0821789D0 (en) | Formulations | |
PL2207567T3 (pl) | Preparat immunogenny | |
GB0707463D0 (en) | Formulation | |
EP2307021A4 (en) | FORMULATIONS | |
GB0822633D0 (en) | Formulation | |
GB0810232D0 (en) | Formulations | |
GB0800788D0 (en) | Niovel formulation | |
GB0715723D0 (en) | Formulation | |
GB0712972D0 (en) | Formulation | |
GB0814376D0 (en) | Formulation | |
GB0705179D0 (en) | Formulations | |
ZA200806951B (en) | Homeopathy-based formulation | |
GB0822394D0 (en) | Formulations |